The Life Sciences team advised NanoMosaic Inc. on the intellectual property aspects of NanoMosaic’s oversubscribed $40,750,000 Series A financing round.
NanoMosaic is a TigerGene-founded company that has established itself as the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and multi-omics applications. Aiming to break the bottleneck in protein biomarker interrogation, NanoMosaic has developed a suite of analyte interrogation technologies and has successfully exported its platform to leading hospitals and institutes.
The round was led by RA Capital Management, joined by Insight Partners, Pura Vida Investments, Time BioVentures, and TigerGene.
The Goodwin team was led by Duncan Greenhalgh and included Natasha Us.
For more details, read the press release and articles in GenomeWeb and Private Equity Wire.